Mikael Sodergren MBChB, DIC, PhD, FRCS is a Senior Clinical Lecturer at Imperial College London and Consultant Hepatobiliary & Pancreatic Surgeon at Imperial College Healthcare NHS Trust.
His clinical interests include complex pancreas, liver & gallbladder cancer surgery as well as laparoscopic & robotic approaches. He was part of the team that pioneered and carried out the first cases of natural orifice translumenal endoscopic surgery (NOTES) in the UK.
His research portfolio is based on novel technological innovation & therapeutics with the following major themes:
1) Immunomodulatory Cancer Therapies with a focus on radiofrequency ablation, saRNA and aptamer technologies applied to hepatocellular carcinoma and pancreatic ductal adenocarcinoma
2) He leads the Medical Cannabis Research Group - a research programme which evaluates and develops novel therapies targeting the endocannabinoid system through a framework of in vitro, in vivo and clinical translational activities
4) Medical Eye-Tracking - investigating the innovative application of this technology to improve outcomes in patients undergoing surgery and other medical interventions
et al., 2021, Splenocystojejunostomy for the treatment of a symptomatic splenic pseudocyst, Annals of the Royal College of Surgeons of England, Vol:103, ISSN:0035-8843, Pages:E202-E205
et al., 2021, An initial analysis of the UK Medical Cannabis Registry: Outcomes analysis of first 129 patients., Neuropsychopharmacol Rep
et al., 2021, Visual gaze patterns reveal surgeons' ability to identify risk of bile duct injury during laparoscopic cholecystectomy, Hpb, Vol:23, ISSN:1365-182X, Pages:715-722
et al., 2021, PRIME-HCC: Phase Ib study of neoadjuvant ipilimumab and nivolumab prior to liver resection for hepatocellular carcinoma, Bmc Cancer, Vol:21, ISSN:1471-2407
et al., 2021, The Identification of Gaze Behaviour and Physiological Markers Associated With Making An Error During Laparoscopic Cholecystectomy, OXFORD UNIV PRESS, ISSN:0007-1323